Quick facts
- A procalcitonin assay measures procalcitonin (PCT) in blood to support the assessment of a patient with suspected sepsis.
- In the United States it files under 21 CFR 866.3215 at Class II, product code PRI for a procalcitonin assay, within a device family named for the assessment of suspected sepsis.
- In Canada it is an in vitro diagnostic device; reading Part 2 of Schedule 1 it reaches Class III, because a life-threatening disease and the consequence of an erroneous result both apply.
- The published performance standard that applies to PCT is set out by the manufacturer and audited in the laboratory's own quality system; the class sets the licence path, not the cut-off.
- A near-patient (point-of-care) format and a laboratory analyser are described by the same device family; Part 2 Rule 6 lifts a near-patient IVDD to Class III in any case.
- Entries, classes and product codes below were checked against the eCFR, the Regulations and the openFDA classification database on 2026-10-13.
A procalcitonin assay measures procalcitonin, a peptide that rises in the blood in systemic bacterial infection and falls as the infection resolves. It is run on a clinical analyser or a near-patient reader and reported alongside the clinical picture to support the assessment of a patient with suspected sepsis and the decisions that follow. In the United States it sits in a named regulation number at Class II; in Canada it is an in vitro diagnostic device that reaches Class III through the rules for diagnosis and patient management. This article sets out both routes and the records the result supports, with the graduated specimen cups that move through the same pre-analytical bench.
What is a procalcitonin assay?
Procalcitonin is the prohormone of calcitonin. In health its concentration in blood is low; in a systemic bacterial infection it can rise sharply, and it falls again as the infection is controlled. An immunoassay on a serum or plasma sample quantifies the peptide, and the result is reported as a concentration that the clinician reads together with the history, the examination and other markers.
Two things separate it from a culture. A culture identifies the organism and takes hours to days; a PCT result is available quickly and tracks the host response rather than the organism. That is why the assay is used where a fast signal is needed to support a decision about a patient with suspected sepsis, and why the same assay is used to follow the response to treatment over days.
What class is a procalcitonin assay in the United States?
It is Class II. 21 CFR 866.3215 is titled Device to detect and measure non-microbial analyte(s) in human clinical specimens to aid in assessment of patients with suspected sepsis, and the openFDA device classification API lists product code PRI for a Procalcitonin Assay, alongside PMT for the broader detect-and-measure family. A Class II device of this kind reaches the market through the premarket notification route with the controls the regulation sets.
The regulation is written around the analyte and the claim, not the platform. A cartridge read on a benchtop analyser and a test run on a larger instrument are described by the same device family when the claim is the same, because the class attaches to what the assay reports and what it is for.
| Item | Detail |
|---|---|
| US regulation | 21 CFR 866.3215 - Device to detect and measure non-microbial analyte(s) in human clinical specimens to aid in assessment of patients with suspected sepsis |
| US class | Class II |
| Product codes | PRI (procalcitonin assay), PMT (detect-and-measure sepsis family) |
| Route to market | Premarket notification before commercial distribution |
| Sample | Serum or plasma from a venepuncture specimen |
How does Canada classify a procalcitonin assay?
Canada treats it as an in vitro diagnostic device and reads Part 2 of Schedule 1 of the Medical Devices Regulations. The governing rule is Rule 3: "An IVDD that is intended to be used for patient management is classified as Class II, unless it falls into one of the following categories, in which case it is classified as Class III: (a) it is intended to be used for the management of patients suffering from a life-threatening disease; or (b) there is a risk that an erroneous result will lead to a patient management decision resulting in an imminent life-threatening situation for the patient." A PCT result is used in the management of a patient in whom sepsis — a life-threatening disease — is suspected, and an erroneous result can drive an imminent life-threatening decision, so both (a) and (b) are engaged and the class is Class III.
The parallel route confirms the same answer. Rule 4 sets other diagnostic IVDDs at Class II unless one of six categories applies, and category (d) is a risk that an erroneous diagnostic result would cause death or severe disability to the patient. For a PCT assay used in suspected sepsis, that risk is the intended-use scenario, not an edge case, so Rule 4(d) points to Class III as well. Rule 6 is a third confirmation: a near-patient IVDD is classified as Class III regardless of the other rules, so a point-of-care PCT cartridge reaches Class III on that basis alone.
| Item | Canada | United States |
|---|---|---|
| Named entry | None; classified by rule (IVDD, Part 2) | 866.3215, Class II |
| Class | Class III (Part 2 Rules 3 and 4) | Class II |
| Governing text | Schedule 1, Part 2, Rules 3, 4 and 6 | 21 CFR 866.3215 |
| Route to market | Device licence (Class III) with ISO 13485 evidence | Premarket notification |
| Near-patient format | Class III (Rule 6) | Handled inside the Class II entry |
Why do the two countries land on different classes?
The difference is real, and it comes from the shape of the two rulebooks. The United States writes a named entry for the device to aid in assessment of patients with suspected sepsis and fixes it at Class II, with the controls that follow set by the premarket notification. Canada does not name the assay; it decides what the device is for, and a device for the management of a life-threatening disease is placed at Class III by the general IVDD rules.
The practical consequence for a laboratory is that the Canadian path carries a Class III device licence, with the quality-system evidence that class attracts, while the US path is a premarket notification. A product already cleared in the United States therefore cannot be assumed to be licensed in Canada on the strength of that clearance; the Canadian route is assessed on its own terms and can land one class higher.
The same logic reaches the accessories. A calibrator or a control sold for use with the assay is described with the IVDD it supports, and Part 2 Rule 7 provides that where an IVDD is intended to be used with another IVDD, the class of both is that of the higher-risk member of the pair. A purchaser should therefore reconcile the assay, its calibrators and its controls as one system rather than as separate line items.
What should a laboratory check before ordering one?
Three checks. First, confirm the exact regulation number, the product code and the intended use on the supplier's labelling, because the class attaches to the claim the assay carries. Second, confirm whether the format is laboratory or near-patient, since the near-patient format reaches Class III in Canada on its own footing. Third, confirm the lot-and-control trace the laboratory will keep, because a Class III IVDD is followed through the quality system rather than by a single result.
A diagnostic laboratory also reorders the pre-analytical bench consumables that move with the same specimen line. The wider laboratory consumables range is listed under diagnostic laboratories. Clinics that stock for a whole practice can order through the wholesale programme and request a bulk quote for a standing or annual order; the graduated specimen cups sits in the same catalogue. Reselling? become a distributor.
How does the class affect a laboratory's routine?
The class sets the licence path; the laboratory's quality system sets the routine. A PCT result is recorded with the specimen, the analyser, the lot of reagent and control used, and the result reported, so a result can be traced back to the run that produced it. The dimensional and lot records are the ordinary evidence a laboratory keeps under its quality system, where ISO 15189 sits.
Because the result informs a decision about a patient who may be critically ill, the report is also handled as an urgent one: the critical-result pathway applies, and the record shows who was called and when. None of that changes with the class; it is the ordinary routine a clinical laboratory keeps, and the record is what shows it was followed.
Sources
- openFDA device classification API
- Medical Devices Regulations, SOR/98-282, full text and Schedule 1
- Clinical and Laboratory Standards Institute
- Public Health Ontario, infection prevention and control
- ISO 15189:2022, medical laboratories, requirements for quality and competence
- World Health Organization
- US FDA, medical device databases
- US FDA, overview of device regulation
- Health Canada, medical devices
- Health Canada, establishment licensing
- Standards Council of Canada
- CSA Group
- ISO 13485:2016, medical devices quality management
- ISO 14971:2019, application of risk management to medical devices
- CCOHS, OSH answers
- ISO 15197:2013, in vitro diagnostic test systems, requirements for blood-glucose monitoring
- Health Canada, medical device licence application guidance
Printable record sheet. A laboratory keeps a printed evidence copy of its run records, and a printable sheet is the copy that goes into the quality file. Open the sterilization log sheet library — the downloadable pack holds a steam-cycle log, a reprocessing-room checklist and an equipment-maintenance sheet. No account and no sign-up; print as many copies as your log needs.
Log generator. Enter the laboratory name, the analyser and the assay menu once, and the generator produces a dated run sheet for the month. Run the sterilization log generator to build a dated, facility-labelled cycle sheet you can print or file straight into your quality manual.
Ask a compliance specialist. Whether a PCT assay is Class II or Class III in Canada turns on the rules for diagnosis and patient management; a written answer keyed to your assay and province settles it. Ask a compliance specialist — you get a written answer specific to your equipment and province, with the regulation or standard it is based on cited.
Related reading
- C-reactive protein tests in Canada vs the US
- Cardiac troponin tests in Canada vs the US
- Clinical chemistry analysers in Canada vs the US
CliniEco Medical supplies eye care, laboratory and dental consumables of the kind described in this article. MDEL #35334. This article is written for optometry, laboratory and dental procurement professionals and is not legal advice; the class of a device and the records a practice keeps belong to the manufacturer and to the requirements that apply to it.
Frequently Asked Questions
What class is a procalcitonin assay in the United States?
Class II, under 21 CFR 866.3215, the regulation for devices that detect and measure non-microbial analytes to aid in assessment of patients with suspected sepsis, product code PRI.
What class is it in Canada?
Class III. As an in vitro diagnostic device used in the management of a life-threatening disease and with an erroneous result that could drive an imminent life-threatening decision, it falls within the Class III categories of Part 2 Rules 3 and 4.
Why is the Canadian class higher than the US class?
The United States names the sepsis-assessment device in a Class II regulation. Canada does not name it and instead applies the general IVDD rules, under which a life-threatening disease and the consequence of an erroneous result raise the class to III.
Does a point-of-care version change the class?
A near-patient IVDD is classified as Class III in Canada under Part 2 Rule 6 in any case, so the format does not lower it.
What else is procalcitonin called?
It is also written as PCT, procalcitonin (PCT), and procalcitonin assay; the analyte is the prohormone of calcitonin.
Do calibrators and controls follow the assay's class?
Where an IVDD is intended to be used with another IVDD, Part 2 Rule 7 sets the class of both to that of the higher-risk member, so calibrators and controls are reconciled with the assay they support.